Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPT-TAVI: Pre- vs Post-TAVI Dual Antiplatelet Therapy
NCT03001960Phase 3Unknown
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2017
- Primary completion
- Mar 2018
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised trial of aspirin and clopidogrel in intracranial embolism (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Total volume of new cerebral lesions on MRI after TAVI versus Baseline. Status: unknown.
02
Drugs
aspirinclopidogrel
03
Conditions
intracranial embolism
Beyond the preview
Go deeper on NCT03001960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03001960.